William Blair Investment Management
FLGT icon

William Blair Investment Management’s Fulgent Genetics FLGT Stock Holding History

William Blair Investment Management’s Portfolio FLGT Stock Details FLGT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-629,540
Closed -$3.02M – 440
2017
Q3 		$3.02M Sell
629,540
-10,679
-2% -$61.4K 0.01% 378
2017
Q2 		$4.09M Buy
640,219
+60,508
+10% +$488K 0.01% 363
2017
Q1 		$6.33M Buy
+579,711
New +$6.85M 0.02% 328

Other funds holding FLGT

MA
Mutual Advisors Omaha, Nebraska $4.67B AUM 17.48% 1-Year Est. Return
GIM
Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return
OWIM
Old West Investment Management Los Angeles, California $923M AUM 112.31% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
USAA
United Services Automobile Association San Antonio, Texas $851M AUM 5.13% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
TDC
Thompson Davis & Co Richmond, Virginia $167M AUM 33.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

William Blair Investment Management's FLGT Position: Q4 2017 in Review

William Blair Investment Management sold out of Fulgent Genetics (FLGT) in Q4 2017, closing a stake of 629,540 shares — an estimated $3.02M sold.

William Blair Investment Management first reported a position in FLGT in Q1 2017 and held it in 3 quarters. The position peaked at $6.33M in Q1 2017. 18 funds tracked by Wall St. Rank hold FLGT as of Q4 2017.

  • William Blair Investment Management reported no remaining Fulgent Genetics position as of Q4 2017 after selling out during the quarter.
  • William Blair Investment Management sold 629,540 Fulgent Genetics shares in Q4 2017, an estimated $3.02M.
  • William Blair Investment Management first reported a position in Fulgent Genetics in Q1 2017 and held it in 3 quarters.
  • William Blair Investment Management's Fulgent Genetics position peaked at $6.33M in Q1 2017.
  • 18 funds tracked by Wall St. Rank held Fulgent Genetics as of Q4 2017.

Based on William Blair Investment Management's 13F filing for Q4 2017, filed 14 Feb 2018.